Clinical Trial: Real-world Study on Secukinumab Effectiveness in Biologic-naive Ankylosing Spondylitis (AS) Patients in Korea.

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06905288) titled 'Real-world Study on Secukinumab Effectiveness in Biologic-naive Ankylosing Spondylitis (AS) Patients in Korea.' on March 25.

Brief Summary: This is an observational study to evaluate the effectiveness and safety of secukinumab in participants with AS who have never used TNFi, JAKi, or IL-17i drugs before.

Study Start Date: March 31

Study Type: OBSERVATIONAL

Condition: Ankylosing Spondylitis

Intervention: DRUG: Secukinumab

This is a prospective observational study. There is no treatment allocation. The decision to initiate treatment will be based solely on clinical judgement.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: N...